Sustainable financing of HIV responses
International funding of the HIV response in Eastern Europe and Central Asia has been experiencing significant constraints over recent years.
The Global Fund to Fight AIDS, Tuberculosis and Malaria reassessed its financial forecasts in 2011 and set up a Transitional Funding Mechanism designed to support only programmes that might disrupt essential services if discontinued.
Following this interim emergency period, the Global Fund introduced its New Funding Model which further changed eligibility criteria also affecting countries of Eastern Europe and the CIS currently receiving Global Fund grants.
Many of these countries are still heavily dependent on external funding for their national HIV responses, mainly provided from the Global Fund. The new eligibility criteria places higher demands on domestic financing sources and some countries will fully cease to be eligible for further Global Fund support.
Commitments to universal coverage of essential HIV-related services as expressed by many National Strategic Plans are not yet fulfilled.
Increasing and improving access to prevention and treatment in the Eastern Europe and Central Asia region is crucial for countries to meet their international public health obligations, and to achieve Millennium Development Goal 6, which calls for efforts to halt and start reversing the HIV epidemic, including ensuring universal access to treatment for those who need it the most.
Also, UN member states are in the process of agreeing on the post-2015 agenda and the new Sustainable Development Goals (SDGs) which will re-enforce the UNAIDS Getting-to-Zero Strategy and call for ending the epidemic threat of AIDS by 2030.
Given these shifts, sustainable financing of national HIV responses is a priority concern for many countries in this region. Together with UNAIDS and other co-sponsors, UNDP is providing policy, strategy and technical support to countries particularly in the following areas:
- Accessing affordable and quality HIV medicines;
- Modeling to optimize investments in HIV programmes using a rights-based approach;
- Advising on transition processes of national HIV responses to more cost-efficient investment approaches using domestic and international funding sources;
- Sustaining the critical role of NGOs in the provision of services to key populations at higher risk of HIV infection.
Access to affordable and quality HIV medicines
Our work focuses on legal and regulatory frameworks and affordability and access to antiretroviral medicines (ARVs).
UNDP provides advisory services related to intellectual property rights and trade-related aspects of intellectual property rights (TRIPS) in selected countries of the region.
UNDP provides practical information and analysis to inform countries on strategies to provide affordable, quality ARVs and at quantities needed for universal coverage as per international treatment guidelines.
Support to countries is provided on regulatory frameworks related to registration, licensing and procurement of ARVs with particular focus on populations at higher risk of HIV infection.
Modeling optimized HIV investment approaches using a rights-based approach
UNDP work focuses on supporting countries to develop short-, mid- and long-term investment strategies for their national HIV responses.
The aim is to ensure efficient use of technical and financial resources, the promotion and protection of the rights of people affected and infected by HIV, increased access to essential prevention and treatment services for key populations at higher risk of HIV, and reduced new HIV infections and AIDS-related deaths.
UNDP work is carried out in close collaboration with our partners including UNAIDS, the World Bank and the Global Fund to Fight AIDS, Tuberculosis and Malaria.
- Legal and regulatory frameworks for ARV medicines and treatment in selected countries of Eastern Europe and Central Asia (Supplement)
- Legal and regulatory frameworks for ARV medicines and treatment in selected countries of the Commonwealth of Independent States
- Modelling an Optimised Investment Approach for Tajikistan
- Modelling an Optimised Investment Approach for Uzbekistan
- Case Report from Serbia
- Towards Domestic Financing of National HIV Responses: Lessons Learnt from Croatia